Cancer

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way. Read More

by Jerry Jones Vanderbilt University Medical Center is one of 73 nonprofit hospitals and medical organizations selected for the Southwest Airlines 2014 Medical Transportation Grant Program. It is the fourth year Vanderbilt has received a Southwest transportation grant. The grant is administered by Vanderbilt LifeFlight and will help approximately 60… Read More

Harold “Hal” Moses, the Hortense B. the Ingram Professor of Cancer Research at Vanderbilt University, is the recipient of the 2014 Distinguished Alumni Award — the highest honor for a member of the Vanderbilt alumni community. Read More

Two features of invasive cancer cells — invadopodia and exosomes — are linked together, Vanderbilt University investigators have discovered. Read More

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read More

Vanderbilt University may nominate one candidate for the Rita Allen Foundation Scholars Award Program for 2014. This award provides $550,000 over five years for young investigators involved in research in the cure and treatment of diseases in the fields of cancer, immunology, and neuroscience. Read More

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

Join an upcoming live Facebook Chat in which Vanderbilt-Ingram Cancer Center experts will answer your questions about hereditary cancer risk on Sept. 24 at 6 p.m. Read More

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read More

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read More

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read More

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma. Read More

Kirkland Cancer Center Leaders of West Tennessee Healthcare (WTH) and Vanderbilt University Medical Center today announced an academic affiliation agreement which further establishes a collaborative relationship between the two institutions, now for the creation of new cancer programs in West Tennessee. The new agreement creates a… Read More

(Vanderbilt University) A sore throat can be a symptom of allergies or a cold virus but if the sore throat persists it may be an early symptom of head and neck cancer. Vanderbilt will hold a free head and neck cancer screening day, Friday, May 3, 9 a.m. –… Read More

The future of cancer is becoming clearer. And it’s not looking so good for cancer. Read More

The gene Has2 participates in signaling that is important in developing fingers and toes, and may have relevance for cancer development. Read More

There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine. Read More